183 related articles for article (PubMed ID: 22494866)
21. [Effect of the ischemic post-conditioning on the prevention of the cardio-renal damage in patients with acute ST-segment elevation myocardial infarction after primary percutaneous coronary intervention].
Wang YY; Li T; Liu YW; Liu BJ; Hu XM; Wang Y; Gao WQ; Wu P; Huang L; Li X; Peng WJ; Ning M
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Apr; 45(4):277-282. PubMed ID: 28545277
[No Abstract] [Full Text] [Related]
22. One-year clinical outcome of interventionalist- versus patient-transfer strategies for primary percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction: results from the REVERSE-STEMI study.
Zhang Q; Zhang RY; Qiu JP; Zhang JF; Wang XL; Jiang L; Liao ML; Zhang JS; Hu J; Yang ZK; Shen WF
Circ Cardiovasc Qual Outcomes; 2011 May; 4(3):355-62. PubMed ID: 21521833
[TBL] [Abstract][Full Text] [Related]
23. Intracoronary compared with intravenous bolus abciximab application in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: the randomized Leipzig immediate percutaneous coronary intervention abciximab IV versus IC in ST-elevation myocardial infarction trial.
Thiele H; Schindler K; Friedenberger J; Eitel I; Fürnau G; Grebe E; Erbs S; Linke A; Möbius-Winkler S; Kivelitz D; Schuler G
Circulation; 2008 Jul; 118(1):49-57. PubMed ID: 18559698
[TBL] [Abstract][Full Text] [Related]
24. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".
Bruder O; Breuckmann F; Jensen C; Jochims M; Naber CK; Barkhausen J; Erbel R; Sabin GV;
Herz; 2008 Mar; 33(2):136-42. PubMed ID: 18344033
[TBL] [Abstract][Full Text] [Related]
25. Intracoronary compared to intravenous abciximab in patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention reduces mortality, target vessel revascularization and reinfarction after 1 year.
Iversen AZ; Galatius S; Abildgaard U; Galloe A; Hansen PR; Pedersen S; Engstroem T; Jensen JS
Cardiology; 2011; 120(1):43-9. PubMed ID: 22122887
[TBL] [Abstract][Full Text] [Related]
26. Randomized comparison between tirofiban and abciximab to promote complete ST-resolution in primary angioplasty: results of the facilitated angioplasty with tirofiban or abciximab (FATA) in ST-elevation myocardial infarction trial.
Marzocchi A; Manari A; Piovaccari G; Marrozzini C; Marra S; Magnavacchi P; Sangiorgio P; Marinucci L; Taglieri N; Gordini G; Binetti N; Guiducci V; Franco N; Reggiani ML; Saia F;
Eur Heart J; 2008 Dec; 29(24):2972-80. PubMed ID: 18940887
[TBL] [Abstract][Full Text] [Related]
27. Early abciximab administration before primary percutaneous coronary intervention improves clinical outcome in elderly patients transferred with ST-elevation myocardial infarction: data from the EUROTRANSFER registry.
Dziewierz A; Siudak Z; Rakowski T; Chyrchel M; Mielecki W; Janzon M; Birkemeyer R; Tierala I; Wojdyła RM; Dubiel JS; Dudek D
Int J Cardiol; 2010 Aug; 143(2):147-53. PubMed ID: 19559491
[TBL] [Abstract][Full Text] [Related]
28. Safety of lone thrombus aspiration without concomitant coronary stenting in selected patients with acute myocardial infarction.
Escaned J; Echavarría-Pinto M; Gorgadze T; Gonzalo N; Armengol F; Hernández R; Jiménez-Quevedo P; Nuñez-Gil IJ; Pérez-Vizcayno MJ; Alfonso F; Bañuelos C; Ibañez B; García E; Fernández-Ortiz A; Macaya C
EuroIntervention; 2013 Feb; 8(10):1149-56. PubMed ID: 23425541
[TBL] [Abstract][Full Text] [Related]
29. No post-conditioning in the human heart with thrombolysis in myocardial infarction flow 2-3 on admission.
Roubille F; Mewton N; Elbaz M; Roth O; Prunier F; Cung TT; Piot C; Roncalli J; Rioufol G; Bonnefoy-Cudraz E; Wiedemann JY; Furber A; Jacquemin L; Willoteaux S; Abi-Khallil W; Sanchez I; Finet G; Sibellas F; Ranc S; Boussaha I; Croisille P; Ovize M
Eur Heart J; 2014 Jul; 35(25):1675-82. PubMed ID: 24585265
[TBL] [Abstract][Full Text] [Related]
30. Surrogate and clinical outcomes following ischemic postconditioning during primary percutaneous coronary intervention of ST--segment elevation myocardial infarction: a meta-analysis of 15 randomized trials.
Khalili H; Patel VG; Mayo HG; de Lemos JA; Brilakis ES; Banerjee S; Bavry AA; Bhatt DL; Kumbhani DJ
Catheter Cardiovasc Interv; 2014 Nov; 84(6):978-86. PubMed ID: 24948465
[TBL] [Abstract][Full Text] [Related]
31. Thrombus aspiration during primary percutaneous coronary intervention improves myocardial reperfusion and reduces infarct size: the EXPIRA (thrombectomy with export catheter in infarct-related artery during primary percutaneous coronary intervention) prospective, randomized trial.
Sardella G; Mancone M; Bucciarelli-Ducci C; Agati L; Scardala R; Carbone I; Francone M; Di Roma A; Benedetti G; Conti G; Fedele F
J Am Coll Cardiol; 2009 Jan; 53(4):309-15. PubMed ID: 19161878
[TBL] [Abstract][Full Text] [Related]
32. Postconditioning in patients treated with primary percutaneous coronary intervention: an updated meta-analysis.
Wang L; Wang J; Xu H; Li B
Catheter Cardiovasc Interv; 2013 Nov; 82(5):E662-71. PubMed ID: 23804529
[TBL] [Abstract][Full Text] [Related]
33. Three hours continuous injection of adenosine improved left ventricular function and infarct size in patients with ST-segment elevation myocardial infarction.
Zhang H; Tian NL; Hu ZY; Wang F; Chen L; Zhang YJ; Chen SL
Chin Med J (Engl); 2012 May; 125(10):1713-9. PubMed ID: 22800889
[TBL] [Abstract][Full Text] [Related]
34. Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of ST-segment elevation myocardial infarction (CICERO) trial.
Gu YL; Kampinga MA; Wieringa WG; Fokkema ML; Nijsten MW; Hillege HL; van den Heuvel AF; Tan ES; Pundziute G; van der Werf R; Hoseyni Guyomi S; van der Horst IC; Zijlstra F; de Smet BJ
Circulation; 2010 Dec; 122(25):2709-17. PubMed ID: 21098442
[TBL] [Abstract][Full Text] [Related]
35. Reduction in myocardial infarct size by postconditioning in patients after percutaneous coronary intervention.
Yang XC; Liu Y; Wang LF; Cui L; Wang T; Ge YG; Wang HS; Li WM; Xu L; Ni ZH; Liu SH; Zhang L; Jia HM; Vinten-Johansen J; Zhao ZQ
J Invasive Cardiol; 2007 Oct; 19(10):424-30. PubMed ID: 17906344
[TBL] [Abstract][Full Text] [Related]
36. Effects of early abciximab administration before primary percutaneous coronary intervention on left ventricular function assessed by cardiac magnetic resonance.
Rakowski T; Mielecki W; Brzozowska-Czarnek A; Dziewierz A; Siudak Z; Legutko J; Rzeszutko L; Urbanik A; Dubiel JS; Dudek D
Kardiol Pol; 2008 Jun; 66(6):617-22; discussion 623. PubMed ID: 18626830
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of postprocedural sustained ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention (from the HORIZONS-AMI Trial).
Mehta RH; Yu J; Piccini JP; Tcheng JE; Farkouh ME; Reiffel J; Fahy M; Mehran R; Stone GW
Am J Cardiol; 2012 Mar; 109(6):805-12. PubMed ID: 22196782
[TBL] [Abstract][Full Text] [Related]
38. Impact of multiple balloon inflations during primary percutaneous coronary intervention on infarct size and long-term clinical outcomes in ST-segment elevation myocardial infarction: real-world postconditioning.
Yetgin T; Magro M; Manintveld OC; Nauta ST; Cheng JM; den Uil CA; Simsek C; Hersbach F; van Domburg RT; Boersma E; Serruys PW; Duncker DJ; van Geuns RJ; Zijlstra F
Basic Res Cardiol; 2014 Mar; 109(2):403. PubMed ID: 24481769
[TBL] [Abstract][Full Text] [Related]
39. Primary coronary intervention in diabetic octogenarians with acute ST elevation myocardial infarction.
Sosnowski C; Janeczko-Sosnowska E; Woźniak J; Jasiński B; Dabrowski R; Sumiński A; Wiernikowski A; Ostrzycki A; Szwed H; Ruzyłło W
Kardiol Pol; 2007 Oct; 65(10):1181-6; discussion 1187-9. PubMed ID: 17979046
[TBL] [Abstract][Full Text] [Related]
40. Impact of infarct related artery patency after early abciximab administration on one-year mortality in patients with ST-segment elevation myocardial infarction (data from the EUROTRANSFER Registry).
Rakowski T; Siudak Z; Dziewierz A; Birkemeyer R; Janzon M; Mielecki W; Zmudka K; Dubiel JS; Dudek D
Kardiol Pol; 2012; 70(3):215-21. PubMed ID: 22430397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
